Update on the genus Trichosporon

Mycopathologia

Volumn 166, Issue 3, 2008, Pages 121-132

  Chagas Neto, Thomas C ^a   Chaves, Guilherme M ^a   Colombo, Arnaldo L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal drugs; Emergent pathogen; Epidemiology; Trichosporon; Yeast identification

Indexed keywords

ANTIFUNGAL AGENT;

CLASSIFICATION; COMMUNICABLE DISEASE; DRUG EFFECT; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; REVIEW; SPECIES DIFFERENCE; TRICHOSPORON;

ANTIFUNGAL AGENTS; COMMUNICABLE DISEASES, EMERGING; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES; SPECIES SPECIFICITY; TRICHOSPORON;

FUNGI; TRICHOSPORON (UNCLASSIFIED); TRICHOSPORON CUTANEUM;

EID: 49249122396     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-008-9136-x     Document Type: Review

References (84)

1. Walsh TJ. Role of surveillance cultures in prevention and treatment of fungal infections. NCI Monogr. 1990;9:43-5.
2. TJ Walsh JW Lee GP Melcher E Navarro J Bacher D Callender 1992 Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis J Infect Dis 166 1 121 33
3. N Lussier M Laverdiere J Delorme K Weiss R Dandavino 2000 Trichosporon beigelii funguria in renal transplant recipients Clin Infect Dis 31 5 1299 301 10.1086/317463
4. TJ Walsh A Groll J Hiemenz R Fleming E Roilides E Anaissie 2004 Infections due to emerging and uncommon medically important fungal pathogens Clin Microbiol Infect 10 Suppl 1 48 66 10.1111/j.1470-9465.2004.00839.x
5. De Hoogs GS, Guarro J, Gene J, Figueras MJ. Atlas of clinical fungi. 2th ed. Rio de Janeiro: Guanabara; 2000.
6. M Arce R Arenas 1998 Infecções dermatológicas por Trichosporon beigelli: estudo retrospectivo de 12 casos em pacientes imunocompetentes An Bras Dermatol 73 13 5
7. EJ Anaissie GP Bodey MG Rinaldi 1989 Emerging fungal pathogens Eur J Clin Microbiol Infect Dis 8 4 323 30 10.1007/BF01963467
8. J Hoy KC Hsu K Rolston RL Hopfer M Luna GP Bodey 1986 Trichosporon beigelii infection: a review Rev Infect Dis 8 6 959 67
9. TJ Walsh KR Newman M Moody RC Wharton JC Wade 1986 Trichosporonosis in patients with neoplastic disease Medicine 65 4 268 79 10.1097/00005792- 198607000-00005
10. TJ Walsh 1989 Trichosporonosis Infect Dis Clin North Am 3 1 43 52
11. R Herbrecht J Waller P Dufour H Koenig B Lioure L Marcellin 1992 Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression 33 Spec No 2 77 80
12. E Gueho GS de Hoog MT Smith 1992 Neotypification of the genus Trichosporon Antonie Van Leeuwenhoek 61 4 285 8 10.1007/BF00713937
13. E Gueho MT Smith GS de Hoog G Billon-Grand R Christen WH Batenburg-van der Vegte 1992 Contributions to a revision of the genus Trichosporon Antonie Van Leeuwenhoek 61 4 289 316 10.1007/BF00713938
14. G Behrend 1890 Ueber Trichomycosis nodosa (Juhel-Rénoy): Piedra (Osorio) Klin Wschr 27 464 7
15. T Sugita A Nishikawa T Shinoda 1994 Reclassification of Trichosporon cutaneum by DNA relatedness by using the spectrophotometric method and chemiluminometric method J Gen Appl Microbiol 40 397 408 10.2323/jgam.40.397
16. T Sugita A Nishikawa T Shinoda H Kume 1995 Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients J Clin Microbiol 33 5 1368 70
17. E Gueho L Improvisi GS de Hoog B Dupont 1994 Trichosporon on humans: a practical account Mycoses 37 1-2 3 10
18. T Sugita M Nakajima R Ikeda T Matsushima T Shinoda 2002 Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species J Clin Microbiol 40 5 1826 30 10.1128/JCM.40.5.1826-1830.2002
19. Middelhoven WJ, Scorzetti G, Fell JW. Systematics of the anamorphic basidiomycetous yeast genus Trichosporon Behrend with the description of five novel species: Trichosporon vadense, T. smithiae, T. dehoogii, T. scarabaeorum and T. gamsii. Int J Syst Evol Microbiol 2004. 54(Pt 3):975-86. doi: 10.1099/ijs.0.02859-0
20. T Sugita R Ikeda A Nishikawa 2004 Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis J Clin Microbiol 42 12 5467 1 10.1128/JCM.42.12.5467-5471.2004
21. Molnar O, Schatzmayr G, Fuchs E, Prillinger H. Trichosporon mycotoxinivorans sp. nov., a new yeast species useful in biological detoxification of various mycotoxins. Syst Appl Microbiol. 2004; 27(6):661-71. doi: 10.1078/0723202042369947.
22. AM Fuentefria SO Suh MF Landell J Faganello A Schrank MH Vainstein 2008 Trichosporon insectorum sp. nov., a new anamorphic basidiomycetous killer yeast Mycol Res 112 Pt 1 93 9 10.1016/j.mycres.2007.05.001
23. JW Fell G Scorzetti 2004 Reassignment of the basidiomycetous yeasts Trichosporon pullulans to Guehomyces pullulans gen nov. comb. nov., and Hyalodendron lignicola to Trichosporon lignicola comb. nov. Int J Syst Evol Microbiol 54 3 995 8 10.1099/ijs.0.03017-0
24. AH Groll TJ Walsh 2001 Uncommon opportunistic fungi: new nosocomial threats Clin Microbiol Infect 7 Suppl 2 8 24 10.1111/j.1469-0691.2001.tb00005.x
25. Kataoka-Nishimura S, Akiyama H, Saku K, Kashiwa M, Mori S, Tanikawa S, et al. Invasive infection due to Trichosporon cutaneum in patients with hematologic malignancies. Cancer 1998; 82(3):484-7. doi:10.1002/(SICI)1097- 0142(19980201)82:3≤484::AID-CNCR9≥3.0.CO;2-P.
26. C Archer-Dubon R Orozco-Topete J Leyva-Santiago R Arenas J Carbajosa A Ysunza 2003 Superficial mycotic infections of the foot in a native pediatric population: a pathogenic role for Trichosporon cutaneum? Pediatr Dermatol 20 4 299 302 10.1046/j.1525-1470.2003.20403.x
27. V Krcmery Jr F Mateicka A Kunova S Spanik J Gyarfas Z Sycova 1999 Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol Support Care Cancer 7 1 39 43 10.1007/s005200050221
28. AA Padhye S Verghese P Ravichandran G Balamurugan L Hall P Padmaja 2003 Trichosporon loubieri infection in a patient with adult polycystic kidney disease J Clin Microbiol 41 1 479 82 10.1128/JCM.41.1.479-482.2003
29. LJ Mendez-Tovar A Anides-Fonseca A Vazquez-Hernandez M Galindo-Gonzalez M Diaz-Madrid A Berdon-Castro 2006 Micosis among five highly underprivileged Mexican communities Gac Med Mex 142 5 381 6
30. J Ruiz-Esmenjaud R Arenas M Rodriguez-Alvarez E Monroy R Felipe Fernandez 2003 Tinea pedis and Onychomycosis in Children of the Mazahua Indian Community in Mexico Gac Med Mex 139 3 215 20
31. ZB Pontes AL Ramos O Lima Ede F Guerra Mde NM Oliveira JP Santos 2002 Clinical and mycological study of scalp white piedra in the State of Paraiba, Brazil Mem Inst Oswaldo Cruz 97 5 747 50 10.1590/S0074-02762002000500028
32. Y Nishiura K Nakagawa-Yoshida M Suga T Shinoda E Gueho M Ando 1997 Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis J Med Vet Mycol 35 1 45 52 10.1080/02681219780000861
33. M Therizol-Ferly M Kombila M Gomez de Diaz C Douchet Y Salaun A Barrabes 1994 White piedra and Trichosporon species in equatorial Africa. II. Clinical and mycological associations: an analysis of 449 superficial inguinal specimens Mycoses 37 7-8 255 60
34. CG Yoo YW Kim SK Han K Nakagawa M Suga Y Nishiura 1997 Summer-type hypersensitivity pneumonitis outside Japan: a case report and the state of the art Respirology (Carlton, Vic) 2 1 75 7
35. HB Kaltreider 1993 Hypersensitivity pneumonitis West J Med 159 5 570 8
36. T Mizobe M Ando H Yamasaki K Onoue A Misaki 1995 Purification and characterization of the serotype-specific polysaccharide antigen of Trichosporon cutaneum serotype II: a disease-related antigen of Japanese summer-type hypersensitivity pneumonitis Clin Exp Allergy 25 3 265 72 10.1111/j.1365-2222. 1995.tb01039.x
37. Fleming RV, Walsh TJ, Anaissie EJ. Emerging and less common fungal pathogens. Infect Dis Clin North Am. 2002;16(4):915-33, vi-vii. doi: 10.1016/S0891-5520(02)00041-7
38. AL Colombo AS Melo RF Crespo Rosas R Salomao M Briones RJ Hollis 2003 Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy Diagn Microbiol Infect Dis 46 4 253 7 10.1016/S0732-8893(03)00079-8
39. VL da Matta M de Souza Carvalho Melhem AL Colombo ML Moretti L Rodero GM Duboc de Almeida 2007 Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia Antimicrob Agents Chemother 51 4 1573 6 10.1128/AAC.01038-06
40. AC Pasqualotto TC Sukiennik LC Severo CS de Amorim AL Colombo 2005 An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit Infect Control Hosp Epidemiol 26 6 553 8 10.1086/502583
41. FF Tuon GM de Almeida SF Costa 2007 Central venous catheter-associated fungemia due to Rhodotorula spp.-a systematic review Med Mycol 45 5 441 7 10.1080/13693780701381289
42. JP Manzella IJ Berman MD Kukrika 1982 Trichosporon beigelii fungemia and cutaneous dissemination Arch Dermatol 118 5 343 5 10.1001/archderm.118.5.343
43. HH Reinhart DM Urbanski SD Harrington JD Sobel 1988 Prosthetic valve endocarditis caused by Trichosporon beigelii Am J Med 84 2 355 8 10.1016/0002-9343(88)90440-8
44. JO Lopes SH Alves C Klock LT Oliveira NR Dal Forno 1997 Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review Mycopathologia 139 1 15 8 10.1023/A:1006870017725
45. ML Moretti-Branchini K Fukushima AZ Schreiber K Nishimura PM Papaiordanou P Trabasso 2001 Trichosporon species infection in bone marrow transplanted patients Diagn Microbiol Infect Dis 39 3 161 4 10.1016/S0732-8893(01)00215-2
46. MH Meyer V Letscher-Bru J Waller P Lutz L Marcellin R Herbrecht 2002 Chronic disseminated Trichosporon asahii infection in a leukemic child Clin Infect Dis 35 2 e22 5 10.1086/340983
47. E Abdala RI Lopes CN Chaves EM Heins-Vaccari MA Shikanai-Yasuda 2005 Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation Transpl Infect Dis 7 3-4 162 5 10.1111/j.1399-3062.2005.00104.x
48. C Girmenia L Pagano B Martino D D'Antonio R Fanci G Specchia 2005 Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature J Clin Microbiol 43 4 1818 28 10.1128/JCM.43.4.1818-1828.2005
49. R Herbrecht KL Liu H Koenig J Waller P Dufour L Marcellin 1992 [Trichosporon capitatum septicemia. Apropos of 5 cases] Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression 33 Spec No 2 96 8
50. VL Rastogi PS Nirwan 2007 Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report Indian J Med Microbiol 25 1 59 61
51. JL Rodriguez-Tudela TM Diaz-Guerra E Mellado V Cano C Tapia A Perkins 2005 Susceptibility patterns and molecular identification of Trichosporon species Antimicrob Agents Chemother 49 10 4026 34 10.1128/AAC.49.10.4026-4034. 2005
52. DE Ciardo G Schar EC Bottger M Altwegg PP Bosshard 2006 Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts J Clin Microbiol 44 1 77 84 10.1128/JCM.44.1.77-84. 2006
53. T Sugita A Nishikawa T Shinoda 1998 Rapid detection of species of the opportunistic yeast Trichosporon by PCR J Clin Microbiol 36 5 1458 60
54. DH Pincus S Orenga S Chatellier 2007 Yeast identification-past, present, and future methods Med Mycol 45 2 97 121 10.1080/13693780601059936
55. S Arikan G Hascelik 2002 Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates Diagn Microbiol Infect Dis 43 2 107 11 10.1016/S0732-8893(02)00376-0
56. K Perparim H Nagai A Hashimoto Y Goto T Tashiro M Nasu 1996 In vitro susceptibility of Trichosporon beigelii to antifungal agents J Chemother (Florence, Italy) 8 6 445 8
57. O Uzun S Arikan S Kocagoz B Sancak S Unal 2000 Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading Diagn Microbiol Infect Dis 38 2 101 7 10.1016/S0732-8893(00)00177-2
58. MA Pfaller M Bale B Buschelman M Lancaster A Espinel-Ingroff JH Rex 1995 Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine J Clin Microbiol 33 5 1104 7
59. T Sugita K Makimura A Nishikawa K Uchida H Yamaguchi T Shinoda 1997 Partial sequences of large subunit ribosomal DNA of a new yeast species, Trichosporon domesticum and related species Microbiol Immunol 41 7 571 3
60. T Sugita A Nishikawa R Ikeda T Shinoda 1999 Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification J Clin Microbiol 37 6 1985 93
61. JL Rodriguez-Tudela A Gomez-Lopez A Alastruey-Izquierdo E Mellado L Bernal-Martinez M Cuenca-Estrella 2007 Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1 Diagn Microbiol Infect Dis 58 4 435 40 10.1016/j.diagmicrobio.2007.03.001
62. MR Diaz JW Fell 2004 High-throughput detection of pathogenic yeasts of the genus trichosporon J Clin Microbiol 42 8 3696 706 10.1128/JCM.42.8.3696- 3706.2004
63. EUCAST 2008 Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts Clin Microbiol Infect 14 4 398 405 10.1111/j.1469-0691.2007.01935.x
64. V Chaturvedi R Ramani JH Rex 2004 Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates J Clin Microbiol 42 5 2252 4 10.1128/JCM.42.5.2252-2254.2004
65. DR Hospenthal CK Murray MG Rinaldi 2004 The role of antifungal susceptibility testing in the therapy of candidiasis Diagn Microbiol Infect Dis 48 3 153 60 10.1016/j.diagmicrobio.2003.10.003
66. K Hata J Kimura H Miki T Toyosawa T Nakamura K Katsu 1996 In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum Antimicrob Agents Chemother 40 10 2237 42
67. NI Paphitou L Ostrosky-Zeichner VL Paetznick JR Rodriguez E Chen JH Rex 2002 In vitro antifungal susceptibilities of Trichosporon species Antimicrob Agents Chemother 46 4 1144 6 10.1128/AAC.46.4.1144-1146.2002
68. E Anaissie A Gokaslan R Hachem R Rubin G Griffin R Robinson 1992 Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review Clin Infect Dis 15 5 781 7
69. S Tawara F Ikeda K Maki Y Morishita K Otomo N Teratani 2000 In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi Antimicrob Agents Chemother 44 1 57 62
70. MA Pfaller DJ Diekema 2004 Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus J Clin Microbiol 42 10 4419 31 10.1128/JCM.42.10.4419-4431.2004
71. TJ Walsh GP Melcher MG Rinaldi J Lecciones DA McGough P Kelly 1990 Trichosporon beigelii, an emerging pathogen resistant to amphotericin B J Clin Microbiol 28 7 1616 22
72. EJ Anaissie R Hachem NC Karyotakis A Gokaslan MC Dignani LC Stephens 1994 Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis Antimicrob Agents Chemother 38 11 2541 4
73. T Itoh H Hosokawa U Kohdera N Toyazaki Y Asada 1996 Disseminated infection with Trichosporon asahii Mycoses 39 5-6 195 9
74. JC Kim YS Kim CS Park JM Kang BN Kim JH Woo 2001 A case of disseminated Trichosporon beigelii infection in a patient with myelodysplastic syndrome after chemotherapy J Korean Med Sci 16 4 505 8
75. O Karabay MG Madariaga E Kocoglu N Ince E Kandirali 2006 Trichosporon asahii fungemia in a patient with non-hematological malignancy Jpn J Infect Dis 59 2 129 31
76. K Makimura T Suzuki T Tamura M Ikedo R Hanazawa Y Takahashi 2004 Comparative evaluation of standard dilution method and commercial kit for frozen plate antifungal susceptibility testing of yeasts using 200 clinical isolates Microbiol Immunol 48 10 747 53
77. DG Wolf R Falk M Hacham B Theelen T Boekhout G Scorzetti 2001 Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units J Clin Microbiol 39 12 4420 5 10.1128/JCM.39.12.4420-4425.2001
78. D Goodman E Pamer A Jakubowski C Morris K Sepkowitz 2002 Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate Clin Infect Dis 35 3 E35 6 10.1086/341305
79. OA Cornely K Schmitz S Aisenbrey 2002 The first echinocandin: caspofungin Mycoses 45 Suppl 3 56 60
80. A Espinel-Ingroff 1998 Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts J Clin Microbiol 36 10 2950 6
81. M Bassetti F Bisio A Di Biagio I Pierri M Balocco O Soro 2004 Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B J Antimicrob Chemother 54 2 575 7 10.1093/jac/dkh337
82. N Asada H Uryu M Koseki M Takeuchi M Komatsu K Matsue 2006 Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia Clin Infect Dis 43 4 e39 41 10.1086/505970
83. S Fournier W Pavageau M Feuillhade S Deplus AM Zagdanski O Verola 2002 Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia Eur J Clin Microbiol Infect Dis 21 12 892 6
84. K Matsue H Uryu M Koseki N Asada M Takeuchi 2006 Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin Clin Infect Dis 42 6 753 7 10.1086/500323